期刊文献+

PEI-g-MPEG/白细胞介素-10基因传递系统转染背根神经节细胞的体外性能研究 被引量:2

IN VITRO EVALUATION OF INTERLEUKIN-10 GENE DELIVERY INTO DORSAL ROOT GANGLION CELLS MEDIATED BY PEI-g-MPEG
原文传递
导出
摘要 探索非病毒基因载体聚乙二醇-聚乙烯亚胺共聚物(PEI-g-MPEG)介导白细胞介素-10(Interleukin-10,IL-10)体外转染原代培养背根神经节细胞(dorsal root ganglion cells,DRGs)的效果.采用本实验室设计合成的PEI-g-MPEG,与同时携带增强型绿色荧光蛋白报告基因及IL-10基因的真核表达质粒DNA(pDC316-EGFP/IL-10)形成复合物,以脂质体(lipofectamine)复合体系Lipo/pDNA为对照,通过溴乙啶(ethidiumbromide,EB)排斥实验、凝胶阻滞电泳实验、粒径与电位的测定及扫描电镜等实验方法观察PEI-g-MPEG/pDNA的复合效果.并且检测了复合物对DRGs的毒性、转染效果及IL-10的蛋白表达情况.结果表明,PEI-g-MPEG在N/P(PEI-g-MPEG所含的氮原子和质粒DNA中磷原子的摩尔比)为5时可完全复合pDNA;随着N/P的增大,PEI-g-MPEG/pDNA复合物的粒径逐渐减小,而表面电位逐渐增大;在N/P为15时报告基因转染效果和IL-10蛋白表达情况较好,复合物的形貌呈大小均一的球形.PEI-g-MPEG/IL-10基因传递系统对于神经病理性疼痛的基因治疗具有潜在应用价值. The use of non-viral carrier,polyethyleneimine-g-methoxypoly(ethylene glycol)(PEI-g-MPEG) for interleukin-10(IL-10) gene delivery into rat dorsal root ganglion cells(DRGs) was examined in vitro.Electrophoresis,ethidium bromide exclusion,SEM,size and zeta(ζ) potential measurements were performed to characterize the nanocomplex,PEI-g-MPEG/pDNA.In addition,the cytotoxicity,transfection efficiency and IL-10 protein expression level in comparison with lipofectamine as a delivery agent were determined.Results showed that plasmid DNA was completely complexed by PEI-g-MPEG at a nitrogento-phosphor(N/P) ratio of 5.The PEI-g-MPEG/pDNA complexes were well-distributed and spherical with smooth surface.As the proportion of PEI-g-MPEG increased,i.e.when N/P ratio increased from 1 to 30,the size of the PEI-g-MPEG/DNA complexes decreased from 229 nm to 130 nm,while the surface charge increased from-19 mV to 32 mV,which led to the increased cytotoxicity.Flow cytometry revealed that the highest transfection efficiency(24%) using PEI-g-MPEG as a delivery agent was obtained at N/P charge ratio of 15,which was higher than that of lipofectamine(17%) at the same N/P value.After transfection,rat IL-10 expression in DRGs primary culture assessed using ELISA was observed to localize in the cytoplasm at 48 h in concordance with the result obtained for EGFP expression.These results indicated that PEI-g-MPEG could be a potential candidate for gene delivery during the therapy of neuropathic pain.
出处 《高分子学报》 SCIE CAS CSCD 北大核心 2010年第1期79-86,共8页 Acta Polymerica Sinica
基金 国家自然科学基金(基金号50673103) 高等学校博士学科点专项科研基金(基金号20060558083) 广东省基金(基金号7003703和2005A30801002)资助项目
关键词 PEI-g-MPEG DRGS IL-10 神经病理性疼痛 PEI-g-MPEG DRGs IL-10 Neuropathic pain
  • 相关文献

参考文献20

  • 1Goss J R,Goins W F,Glorioso J C. Expert Reviev, of Neurotherapeut cs,2007,7:487 -506.
  • 2Moore K W,de Waal Malefyt R,Coffman R L.O'Garra A. Annual Review of hnmunology,2001,19 :683 -765.
  • 3Milligan E D,Sloane E M,Langer S J,Hughes T S,Jekich B M,Frank M G,Mahoney J H,Levkoff L H,Maier S F,Cruz P E,Flotte T R, Johnson K W,Mahoney M M,Chavez R A,Leinwand L A,Watkins L R. Pain, 2006,126:294 - 308.
  • 4Godbey W T,Wu K K,Mikos A G. J Control Release, 1999,60:149 -160.
  • 5Lungwitz U, Breunig M, Bhlnk T,Gopferieh A. Eur J Pharm Biopharm ,2005,60:247 -266.
  • 6Zaric V,Wehin D,Erbaeher P Remv J S,Behr J P,Stephan D. Journal of Gene Med c ne,2004,6:176 - 184.
  • 7Lee J H, Ahn H lt,Kim K S, Lee J Y, Kim M S, Lee B, Khang G, Lee H B. Journal of Tissue Engineering and Regenerative Medicine,2008, 2:288 - 295.
  • 8Ahn H H,Lee J H,Kim K S,Lee J Y,Kim M S,Khang G,Lee H B. Biomater als,2008 ,29 :2415 -2422.
  • 9Hong J W,Park J H,Huh K M,Chung H,Kwon I C,Jeong S Y. J Control Release ,2004,99:167 - 176.
  • 10Nimesh S, Goyal A, Pawar V, Jayaraman S, Kumar P, Chandra R, Singh Y, Gupta K C. J Control Release,2006,110:457 - 468.

同被引文献30

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部